SANESE, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 1.427
AS - Asia 777
EU - Europa 536
SA - Sud America 224
AF - Africa 66
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.035
Nazione #
US - Stati Uniti d'America 1.371
SG - Singapore 332
BR - Brasile 188
CN - Cina 124
IT - Italia 107
RU - Federazione Russa 105
VN - Vietnam 101
HK - Hong Kong 95
DE - Germania 77
GB - Regno Unito 53
SE - Svezia 49
FR - Francia 38
CA - Canada 33
CI - Costa d'Avorio 32
FI - Finlandia 27
IN - India 26
ID - Indonesia 16
BD - Bangladesh 15
PL - Polonia 15
AT - Austria 14
NL - Olanda 12
ZA - Sudafrica 12
TR - Turchia 11
AR - Argentina 10
MX - Messico 10
JP - Giappone 9
CO - Colombia 8
CZ - Repubblica Ceca 8
EC - Ecuador 8
IQ - Iraq 8
SA - Arabia Saudita 8
LT - Lituania 6
PK - Pakistan 6
BE - Belgio 5
ES - Italia 5
KE - Kenya 5
AU - Australia 4
UZ - Uzbekistan 4
CR - Costa Rica 3
MA - Marocco 3
NG - Nigeria 3
PY - Paraguay 3
UA - Ucraina 3
VE - Venezuela 3
CH - Svizzera 2
DZ - Algeria 2
IE - Irlanda 2
JM - Giamaica 2
KW - Kuwait 2
MY - Malesia 2
NI - Nicaragua 2
OM - Oman 2
PH - Filippine 2
PT - Portogallo 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CL - Cile 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GN - Guinea 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
KZ - Kazakistan 1
LC - Santa Lucia 1
ML - Mali 1
MU - Mauritius 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
SO - Somalia 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.035
Città #
Ashburn 258
Singapore 185
San Jose 148
Fairfield 136
Hong Kong 94
Chandler 88
Houston 62
Woodbridge 61
Beijing 59
Seattle 50
Cambridge 43
Nyköping 39
New York 38
Munich 36
Los Angeles 33
Wilmington 33
Abidjan 32
Dallas 25
Ho Chi Minh City 20
Council Bluffs 19
Lauterbourg 19
Helsinki 18
Frankfurt am Main 17
Hanoi 17
Dong Ket 16
Santa Clara 16
Toronto 16
Brooklyn 14
Jakarta 14
London 14
Warsaw 13
Roxbury 12
São Paulo 11
Bari 10
Inglewood 10
Orem 10
Atlanta 9
Chennai 9
Chicago 9
Indianapolis 9
Tokyo 9
Turku 9
Buffalo 8
Des Moines 8
Lawrence 8
Milan 8
Montreal 8
Nuremberg 8
Olomouc 8
Johannesburg 7
San Francisco 7
Moscow 6
Stockholm 6
Ann Arbor 5
Brussels 5
Denver 5
Düsseldorf 5
Falkenstein 5
Haiphong 5
Mexico City 5
Nairobi 5
Nanjing 5
Ankara 4
Baghdad 4
Barnet 4
Bauru 4
Bexley 4
Cagliari 4
Crispiano 4
Dearborn 4
Guayaquil 4
Manchester 4
Mumbai 4
Noicattaro 4
Poplar 4
Porto Alegre 4
Redwood City 4
Rio de Janeiro 4
Riyadh 4
Rome 4
Tashkent 4
Uberlândia 4
Amsterdam 3
Belo Horizonte 3
Brasília 3
Campinas 3
Caxias do Sul 3
Columbus 3
Da Nang 3
Indaiatuba 3
Jeddah 3
Kilburn 3
Nova Iguaçu 3
Osasco 3
Portsmouth 3
Pune 3
Querétaro 3
Quito 3
Quận Bình Thạnh 3
San Diego 3
Totale 2.001
Nome #
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma 205
A SMYD3 Small-Molecule Inhibitor Impairing Cancer Cell Growth 185
Uncoupling FoxO3A mitochondrial and nuclear functions in cancer cells undergoing metabolic stress and chemotherapy. 185
FOXO3 on the Road to Longevity: Lessons From SNPs and Chromatin Hubs 177
In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS) 169
Gastric polyposis and desmoid tumours as a new familial adenomatous polyposis clinical variant associated with APC mutation at the extreme 3′-end 159
Chasing the Foxo3: Insights into its new mitochondrial lair in colorectal cancer landscape 155
Targeting SMYD3 to Sensitize Homologous Recombination-Proficient Tumors to PARP-Mediated Synthetic Lethality 123
The longevity SNP rs2802292 uncovered: HSF1 activates stress-dependent expression of FOXO3 through an intronic enhancer. 120
CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype 110
Playing on the dark side: Smyd3 acts as a cancer genome keeper in gastrointestinal malignancies 103
Discovery of an allosteric ligand binding site in SMYD3 lysine methyltransferase 102
Discovery of the 4-aminopiperidine-based compound EM127 for the site-specific covalent inhibition of SMYD3 91
The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistance 85
Identification and Somatic Characterization of the Germline PTEN Promoter Variant rs34149102 in a Family with Gastrointestinal and Breast Tumors 84
Identifying novel SMYD3 interactors on the trail of cancer hallmarks 82
SMYD3 Modulates AMPK-mTOR Signaling Balance in Cancer Cell Response to DNA Damage 80
Understanding the Genetic Landscape of Pancreatic Ductal Adenocarcinoma to Support Personalized Medicine: A Systematic Review 76
Coinheritance of germline mutations in APC and MUTYH genes defines the clinical outcome of adenomatous polyposis syndromes 71
Tumor Testing and Genetic Analysis to Identify Lynch Syndrome Patients in an Italian Colorectal Cancer Cohort 70
SMYD3 Modulates the HGF/MET Signaling Pathway in Gastric Cancer 67
c-MYC Protein Stability Is Sustained by MAPKs in Colorectal Cancer 66
Histone and DNA Methylation as Epigenetic Regulators of DNA Damage Repair in Gastric Cancer and Emerging Therapeutic Opportunities 65
The chromatin remodeling factors EP300 and TRRAP are novel SMYD3 interactors involved in the emerging 'nonmutational epigenetic reprogramming' cancer hallmark 64
Identification of a novel germline APC N-terminal pathogenic variant associated with attenuated familial adenomatous polyposis 62
Classic Galactosemia: Clinical and Computational Characterization of a Novel GALT Missense Variant (p.A303D) and a Literature Review 59
Uncoupling p38α nuclear and cytoplasmic functions and identification of two p38α phosphorylation sites on β-catenin: implications for the Wnt signaling pathway in CRC models 56
Exploring the Relationship of rs2802292 with Diabetes and NAFLD in a Southern Italian Cohort-Nutrihep Study 56
Clinical and Molecular Characterization of SMAD4 Splicing Variants in Patients with Juvenile Polyposis Syndrome 52
In Silico Deciphering of the Potential Impact of Variants of Uncertain Significance in Hereditary Colorectal Cancer Syndromes 52
Pharmacological targeting of the novel β-catenin chromatin-associated kinase p38α in colorectal cancer stem cell tumorspheres and organoids 37
An Integrated Clinical, Germline, Somatic, and In Silico Approach to Assess a Novel PMS2 Gene Variant Identified in Two Unrelated Lynch Syndrome Families 17
Deciphering the Causative Role of a Novel APC Gene Variant in Attenuated Familial Adenomatous Polyposis Using Germline DNA-RNA Paired Testing 12
Clinical Assessment and Genetic Testing for Hereditary Polyposis Syndromes in an Italian Cohort of Patients with Colorectal Polyps 12
The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistance 12
Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3/c-MYC axis 10
The Protective Effect of FOXO3 rs2802292 G-Allele on Food Intake in a Southern Italian Cohort Affected by MASLD 9
Methyltransferases in cancer drug resistance: Unlocking the potential of targeting SMYD3 to sensitize cancer cells 9
The Interplay of Genetics and Lifestyle in MASLD: Focus on LPIN1 rs13412852 and Sedentary Behaviour 8
Totale 3.157
Categoria #
all - tutte 11.832
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.832


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202180 0 0 0 0 0 0 0 0 0 33 22 25
2021/2022118 4 10 5 1 4 12 3 6 8 14 16 35
2022/2023189 12 33 14 13 13 32 1 26 39 1 3 2
2023/2024100 2 12 1 5 8 31 4 6 1 10 7 13
2024/2025668 25 9 43 29 23 67 80 68 26 44 71 183
2025/20261.544 234 118 152 160 213 70 118 24 246 209 0 0
Totale 3.157